BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 171 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $475,135 | +35.8% | 18,018 | -11.4% | 0.29% | +39.6% |
| Q2 2023 | $349,934 | -34.6% | 20,345 | -36.9% | 0.21% | -29.6% |
| Q1 2023 | $534,672 | +121.5% | 32,248 | +1.8% | 0.29% | +133.3% |
| Q4 2022 | $241,409 | -32.9% | 31,681 | -12.4% | 0.13% | -12.5% |
| Q3 2022 | $360,000 | +11.1% | 36,175 | +1.5% | 0.14% | +20.0% |
| Q2 2022 | $324,000 | +690.2% | 35,646 | +778.6% | 0.12% | +566.7% |
| Q1 2022 | $41,000 | -43.1% | 4,057 | -5.7% | 0.02% | -33.3% |
| Q4 2021 | $72,000 | -53.8% | 4,304 | +29.0% | 0.03% | -60.9% |
| Q3 2021 | $156,000 | -27.1% | 3,336 | -4.9% | 0.07% | -21.6% |
| Q2 2021 | $214,000 | -29.1% | 3,509 | -28.4% | 0.09% | -31.2% |
| Q1 2021 | $302,000 | -12.0% | 4,902 | +1.7% | 0.13% | -9.9% |
| Q4 2020 | $343,000 | -14.9% | 4,820 | -55.2% | 0.14% | -32.7% |
| Q3 2020 | $403,000 | +1.3% | 10,753 | -11.9% | 0.21% | +12.2% |
| Q2 2020 | $398,000 | +39.2% | 12,211 | +23.8% | 0.19% | +59.3% |
| Q1 2020 | $286,000 | -27.8% | 9,860 | -12.7% | 0.12% | +81.5% |
| Q4 2019 | $396,000 | – | 11,295 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |